Li Yuwen, Caballero Daniel, Ponsetto Julian, Chen Alyssa, Zhu Chuanlong, Guo Jun, Demay Marie, Jüppner Harald, Bergwitz Clemens
Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Department of Pediatrics, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
PLoS One. 2017 Apr 27;12(4):e0176232. doi: 10.1371/journal.pone.0176232. eCollection 2017.
Mutations in the renal sodium-dependent phosphate co-transporters NPT2a and NPT2c have been reported in patients with renal stone disease and nephrocalcinosis, but the relative contribution of genotype, dietary calcium and phosphate to the formation of renal mineral deposits is unclear. We previously reported that renal calcium phosphate deposits persist and/or reappear in older Npt2a-/- mice supplemented with phosphate despite resolution of hypercalciuria while no deposits are seen in wild-type (WT) mice on the same diet. Addition of calcium to their diets further increased calcium phosphate deposits in Npt2a-/-, but not WT mice. The response of PTH to dietary phosphate of Npt2a-/- was blunted when compared to WT mice and the response of the urinary calcium x phosphorus product to the addition of calcium and phosphate to the diet of Npt2a-/- was increased. These finding suggests that Npt2a-/- mice respond differently to dietary phosphate when compared to WT mice. Further evaluation in the Npt2a-/- cohort on different diets suggests that urinary calcium excretion, plasma phosphate and FGF23 levels appear to be positively correlated to renal mineral deposit formation while urine phosphate levels and the urine anion gap, an indirect measure of ammonia excretion, appear to be inversely correlated. Our observations in Npt2a-/- mice, if confirmed in humans, may be relevant for the optimization of existing and the development of novel therapies to prevent nephrolithiasis and nephrocalcinosis in human carriers of NPT2a and NPT2c mutations.
肾结石病和肾钙质沉着症患者中已报道了肾钠依赖性磷酸盐共转运蛋白NPT2a和NPT2c的突变,但基因型、饮食中的钙和磷对肾矿物质沉积形成的相对贡献尚不清楚。我们之前报道过,尽管高钙尿症已缓解,但补充磷酸盐的老年Npt2a-/-小鼠中肾磷酸钙沉积持续存在和/或再次出现,而相同饮食的野生型(WT)小鼠中未见沉积。在它们的饮食中添加钙会进一步增加Npt2a-/-小鼠而非WT小鼠的磷酸钙沉积。与WT小鼠相比,Npt2a-/-小鼠的甲状旁腺激素(PTH)对饮食中磷酸盐的反应减弱,并且Npt2a-/-小鼠饮食中添加钙和磷酸盐后尿钙×磷产物的反应增强。这些发现表明,与WT小鼠相比,Npt2a-/-小鼠对饮食中的磷酸盐反应不同。对不同饮食的Npt2a-/-队列的进一步评估表明,尿钙排泄、血浆磷酸盐和FGF23水平似乎与肾矿物质沉积形成呈正相关,而尿磷酸盐水平和尿阴离子间隙(氨排泄的间接指标)似乎呈负相关。我们在Npt2a-/-小鼠中的观察结果,如果在人类中得到证实,可能与优化现有疗法以及开发新疗法以预防NPT2a和NPT2c突变的人类携带者中的肾结石病和肾钙质沉着症有关。